Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy
Table 4
Association between RNG and clinicopathologic characteristics of LACSCC patients with neutropenia.
Clinicopathologic characteristics
RNG, (%)
value
≥3.01
<3.01
Age
≤50 years
11 (52.4)
10 (47.6)
0.890
>50 years
7 (50.0)
7 (50.0)
Histologic grade
Well and moderately differentiated
7 (50.0)
7 (50.0)
0.890
Poorly differentiated
11 (52.4)
10 (47.6)
Tumor size
≤4 cm
5 (55.6)
4 (44.4)
0.921
>4 cm
13 (50.0)
13 (50.0)
Parametrial invasion
No
6 (42.9)
8 (57.1)
0.462
Unilateral
9 (64.3)
5 (35.7)
Bilateral
3 (42.9)
4 (57.1)
Clinical lymph node involvement
cN0
7 (33.3)
14 (66.7)
0.023
cN1
11 (78.6)
3 (21.4)
FIGO stage
II
9 (52.9)
8 (47.1)
0.862
III
9 (50.0)
9 (50.0)
Hemoglobin levels at diagnosis (g/dL)
≤113
4 (44.4)
5 (55.6)
0.921
>113
14 (53.8)
12 (46.2)
Platelets at diagnosis (g/dL)
≤320
3 (75.0)
1 (25.0)
0.638
>320
15 (48.3)
16 (51.7)
Response
CR
7 (36.8)
12 (63.2)
0.060
Non-CR
11 (68.8)
5 (31.2)
RNG, responses of neutrophil to granulocyte colony-stimulating factors; LACSCC, locally advanced cervical squamous cell carcinomas; FIGO, International Federation of Gynecology and Obstetrics; CR, complete response.
